Schedule 13D ownership disclosure

Tribute Pharmaceuticals Canada Inc.

Security class unavailable · CUSIP: 89609J106

Event date: 2011-12-01

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
7.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001354488-15-001301
Form type
SC 13D
Filer
Elora Financial Management Inc.
CIK
CIK 1536874
Filed
Mar 24, 2015
Reporting period
Dec 01, 2011
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub